Plasmapheresis and specific immunoadsorption in the treatment of myasthenia gravis

Acta Clinica Croatica

Volumn 40, Issue 1, 2001, Pages 39-41

  Kes, P ^a   Basic Kes V ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Myasthenia gravis; Plasmapheresis; Therapy

Indexed keywords

CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR ANTIBODY; PLASMA PROTEIN;

AUTOIMMUNE DISEASE; BINDING AFFINITY; HUMAN; IMMUNOADSORPTION; MYASTHENIA GRAVIS; PLASMAPHERESIS; RECEPTOR BINDING; RECEPTOR BLOCKING; REVIEW; TORPEDO CALIFORNICA;

EID: 0035042820     PISSN: 03539466     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. The utility of therapeutic plasmapheresis for neurological disorders
2. Plasmapheresis in myasthenia gravis
3. Therapeutic plasma exchange in neurologic disorders
4. Myasthenia gravis
5. Seronegative myasthenia gravis
6. Plasma exchange with a rotating filter
7. Myasthenogenic significance of synthetic - Subunit peptide 183-200 of Torpedo Californica and human acetylcholine receptor
8. Specific immunoadsorbent for myasthenia gravis treatment: Development of synthetic peptide designed to remove antiacetylcholine receptor antibody
9. Treatment of myasthenia gravis with a specific immunoadsorbent bound to acetylcholine receptor peptide 183-200